Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Mouse papillomavirus infection persists in mucosal tissues of an immunocompetent mouse strain and progresses to cancer.

Cladel NM, Budgeon LR, Balogh KK, Cooper TK, Brendle SA, Christensen ND, Schell TD, Hu J.

Sci Rep. 2017 Dec 5;7(1):16932. doi: 10.1038/s41598-017-17089-4.

2.

Comparative analysis of fixation and embedding techniques for optimized histological preparation of zebrafish.

Copper JE, Budgeon LR, Foutz CA, van Rossum DB, Vanselow DJ, Hubley MJ, Clark DP, Mandrell DT, Cheng KC.

Comp Biochem Physiol C Toxicol Pharmacol. 2018 Jun;208:38-46. doi: 10.1016/j.cbpc.2017.11.003. Epub 2017 Nov 20.

3.

Mouse papillomavirus infections spread to cutaneous sites with progression to malignancy.

Cladel NM, Budgeon LR, Cooper TK, Balogh KK, Christensen ND, Myers R, Majerciak V, Gotte D, Zheng ZM, Hu J.

J Gen Virol. 2017 Sep 25. doi: 10.1099/jgv.0.000926. [Epub ahead of print]

4.

The Mouse Papillomavirus Infection Model.

Hu J, Cladel NM, Budgeon LR, Balogh KK, Christensen ND.

Viruses. 2017 Aug 30;9(9). pii: E246. doi: 10.3390/v9090246. Review.

5.

Recent advances in preclinical model systems for papillomaviruses.

Christensen ND, Budgeon LR, Cladel NM, Hu J.

Virus Res. 2017 Mar 2;231:108-118. doi: 10.1016/j.virusres.2016.12.004. Epub 2016 Dec 9. Review.

6.

Mouse papillomavirus MmuPV1 infects oral mucosa and preferentially targets the base of the tongue.

Cladel NM, Budgeon LR, Balogh KK, Cooper TK, Hu J, Christensen ND.

Virology. 2016 Jan 15;488:73-80. doi: 10.1016/j.virol.2015.10.030. Epub 2015 Nov 21.

7.

Tracking vaginal, anal and oral infection in a mouse papillomavirus infection model.

Hu J, Budgeon LR, Cladel NM, Balogh K, Myers R, Cooper TK, Christensen ND.

J Gen Virol. 2015 Dec;96(12):3554-65.

8.

A novel pre-clinical murine model to study the life cycle and progression of cervical and anal papillomavirus infections.

Cladel NM, Budgeon LR, Balogh KK, Cooper TK, Hu J, Christensen ND.

PLoS One. 2015 Mar 24;10(3):e0120128. doi: 10.1371/journal.pone.0120128. eCollection 2015.

9.

Protection from tumor recurrence following adoptive immunotherapy varies with host conditioning regimen despite initial regression of autochthonous murine brain tumors.

Cozza EM, Cooper TK, Budgeon LR, Christensen ND, Schell TD.

Cancer Immunol Immunother. 2015 Mar;64(3):325-36. doi: 10.1007/s00262-014-1635-7. Epub 2014 Nov 19.

10.

Efficient replication of Epstein-Barr virus in stratified epithelium in vitro.

Temple RM, Zhu J, Budgeon L, Christensen ND, Meyers C, Sample CE.

Proc Natl Acad Sci U S A. 2014 Nov 18;111(46):16544-9. doi: 10.1073/pnas.1400818111. Epub 2014 Oct 13.

11.

Long-peptide therapeutic vaccination against CRPV-induced papillomas in HLA-A2.1 transgenic rabbits.

Hu J, Budgeon LR, Balogh KK, Peng X, Cladel NM, Christensen ND.

Trials Vaccinol. 2014;3:134-142.

12.

The type 1 diabetes resistance locus B10 Idd9.3 mediates impaired B-cell lymphopoiesis and implicates microRNA-34a in diabetes protection.

Berry GJ, Budgeon LR, Cooper TK, Christensen ND, Waldner H.

Eur J Immunol. 2014 Jun;44(6):1716-27. doi: 10.1002/eji.201344116. Epub 2014 Apr 29.

13.

Vaccines and immunization against human papillomavirus.

Christensen ND, Budgeon LR.

Curr Probl Dermatol. 2014;45:252-64. doi: 10.1159/000356183. Epub 2014 Mar 13.

PMID:
24643192
14.

Secondary infections, expanded tissue tropism, and evidence for malignant potential in immunocompromised mice infected with Mus musculus papillomavirus 1 DNA and virus.

Cladel NM, Budgeon LR, Cooper TK, Balogh KK, Hu J, Christensen ND.

J Virol. 2013 Aug;87(16):9391-5. doi: 10.1128/JVI.00777-13. Epub 2013 Jun 19.

15.

Synonymous codon changes in the oncogenes of the cottontail rabbit papillomavirus lead to increased oncogenicity and immunogenicity of the virus.

Cladel NM, Budgeon LR, Hu J, Balogh KK, Christensen ND.

Virology. 2013 Apr 10;438(2):70-83. doi: 10.1016/j.virol.2013.01.005. Epub 2013 Feb 20.

16.

The innate immune adaptor MyD88 is dispensable for spontaneous autoimmune demyelination in a mouse model of multiple sclerosis.

Wexler AG, Frielle C, Berry G, Budgeon LR, Baccon J, Christensen ND, Waldner H.

J Neuroimmunol. 2013 Feb 15;255(1-2):60-9. doi: 10.1016/j.jneuroim.2012.11.004. Epub 2012 Dec 24.

PMID:
23269203
17.

In vivo programming of tumor antigen-specific T lymphocytes from pluripotent stem cells to promote cancer immunosurveillance.

Lei F, Zhao B, Haque R, Xiong X, Budgeon L, Christensen ND, Wu Y, Song J.

Cancer Res. 2011 Jul 15;71(14):4742-7. doi: 10.1158/0008-5472.CAN-11-0359. Epub 2011 May 31.

18.

Papillomavirus DNA complementation in vivo.

Hu J, Cladel NM, Budgeon L, Balogh KK, Christensen ND.

Virus Res. 2009 Sep;144(1-2):117-22. doi: 10.1016/j.virusres.2009.04.006. Epub 2009 Apr 18.

19.

Detection of L1, infectious virions and anti-L1 antibody in domestic rabbits infected with cottontail rabbit papillomavirus.

Hu J, Budgeon LR, Cladel NM, Culp TD, Balogh KK, Christensen ND.

J Gen Virol. 2007 Dec;88(Pt 12):3286-93.

PMID:
18024897
20.

Establishment of a cottontail rabbit papillomavirus/HLA-A2.1 transgenic rabbit model.

Hu J, Peng X, Budgeon LR, Cladel NM, Balogh KK, Christensen ND.

J Virol. 2007 Jul;81(13):7171-7. Epub 2007 Apr 25.

21.

An HLA-A2.1-transgenic rabbit model to study immunity to papillomavirus infection.

Hu J, Peng X, Schell TD, Budgeon LR, Cladel NM, Christensen ND.

J Immunol. 2006 Dec 1;177(11):8037-45.

22.

Impact of genetic changes to the CRPV genome and their application to the study of pathogenesis in vivo.

Hu J, Cladel NM, Balogh K, Budgeon L, Christensen ND.

Virology. 2007 Feb 20;358(2):384-90. Epub 2006 Oct 4.

23.

Preclinical model to test human papillomavirus virus (HPV) capsid vaccines in vivo using infectious HPV/cottontail rabbit papillomavirus chimeric papillomavirus particles.

Mejia AF, Culp TD, Cladel NM, Balogh KK, Budgeon LR, Buck CB, Christensen ND.

J Virol. 2006 Dec;80(24):12393-7. Epub 2006 Sep 27.

24.

Protective cell-mediated immunity by DNA vaccination against Papillomavirus L1 capsid protein in the Cottontail Rabbit Papillomavirus model.

Hu J, Cladel NM, Budgeon LR, Reed CA, Pickel MD, Christensen ND.

Viral Immunol. 2006 Summer;19(3):492-507.

PMID:
16987067
25.

Papillomavirus particles assembled in 293TT cells are infectious in vivo.

Culp TD, Cladel NM, Balogh KK, Budgeon LR, Mejia AF, Christensen ND.

J Virol. 2006 Nov;80(22):11381-4. Epub 2006 Aug 30.

26.
27.

High-throughput zebrafish histology.

Sabaliauskas NA, Foutz CA, Mest JR, Budgeon LR, Sidor AT, Gershenson JA, Joshi SB, Cheng KC.

Methods. 2006 Jul;39(3):246-54.

PMID:
16870470
28.

The human papillomavirus type 11 E1/\E4 protein is not essential for viral genome amplification.

Fang L, Budgeon LR, Doorbar J, Briggs ER, Howett MK.

Virology. 2006 Aug 1;351(2):271-9. Epub 2006 May 9.

29.

Induction of productive human papillomavirus type 11 life cycle in epithelial cells grown in organotypic raft cultures.

Fang L, Meyers C, Budgeon LR, Howett MK.

Virology. 2006 Mar 30;347(1):28-35. Epub 2006 Feb 7.

30.
31.

Characterization of immune responses during regression of rabbit oral papillomavirus infections.

Wilgenburg BJ, Budgeon LR, Lang CM, Griffith JW, Christensen ND.

Comp Med. 2005 Oct;55(5):431-9.

PMID:
16270899
32.

Comparative safety evaluation of the candidate vaginal microbicide C31G.

Catalone BJ, Kish-Catalone TM, Neely EB, Budgeon LR, Ferguson ML, Stiller C, Miller SR, Malamud D, Krebs FC, Howett MK, Wigdahl B.

Antimicrob Agents Chemother. 2005 Apr;49(4):1509-20.

33.

Characterization of three rabbit oral papillomavirus oncogenes.

Hu J, Cladel NM, Budgeon LR, Christensen ND.

Virology. 2004 Jul 20;325(1):48-55.

34.

A small molecule antagonist of the alpha(v)beta3 integrin suppresses MDA-MB-435 skeletal metastasis.

Harms JF, Welch DR, Samant RS, Shevde LA, Miele ME, Babu GR, Goldberg SF, Gilman VR, Sosnowski DM, Campo DA, Gay CV, Budgeon LR, Mercer R, Jewell J, Mastro AM, Donahue HJ, Erin N, Debies MT, Meehan WJ, Jones AL, Mbalaviele G, Nickols A, Christensen ND, Melly R, Beck LN, Kent J, Rader RK, Kotyk JJ, Pagel MD, Westlin WF, Griggs DW.

Clin Exp Metastasis. 2004;21(2):119-28.

PMID:
15168729
35.

Mouse model of cervicovaginal toxicity and inflammation for preclinical evaluation of topical vaginal microbicides.

Catalone BJ, Kish-Catalone TM, Budgeon LR, Neely EB, Ferguson M, Krebs FC, Howett MK, Labib M, Rando R, Wigdahl B.

Antimicrob Agents Chemother. 2004 May;48(5):1837-47.

36.

Differential antibody responses to a distinct region of human papillomavirus minor capsid proteins.

Embers ME, Budgeon LR, Culp TD, Reed CA, Pickel MD, Christensen ND.

Vaccine. 2004 Jan 26;22(5-6):670-80.

PMID:
14741159
37.

HIV-1 infection in a small animal human vaginal xenograft model.

Kish TM, Ward MG, Welsh PA, Budgeon LR, Wigdahl B, Howett MK.

J Acquir Immune Defic Syndr. 2003 Dec 15;34(5):454-60.

PMID:
14657754
38.

Suppression of human papillomavirus gene expression in vitro and in vivo by herpes simplex virus type 2 infection.

Fang L, Ward MG, Welsh PA, Budgeon LR, Neely EB, Howett MK.

Virology. 2003 Sep 15;314(1):147-60.

39.

Mucosally-derived HPV-40 can infect both human genital foreskin and cutaneous hand skin tissues grafted into athymic mice.

Jenkins AL, Lang CM, Budgeon LR, Cladel NM, Reed CA, Welch DR, Christensen ND.

Virus Res. 2003 May;93(1):109-14. Erratum in: Virus Res. 2003 Jul;94(1):65. Jenkins Audrey J [corrected to Jenkins Audrey L].

PMID:
12727348
40.

Gene gun-mediated intracutaneous vaccination with papillomavirus E7 gene delays cancer development of papillomavirus-induced skin papillomas on rabbits.

Han R, Peng X, Reed CA, Cladel NM, Budgeon LR, Pickel MD, Christensen ND.

Cancer Detect Prev. 2002;26(6):458-67.

PMID:
12507231
41.

Maintaining GFP tissue fluorescence through bone decalcification and long-term storage.

Harms JF, Budgeon LR, Christensen ND, Welch DR.

Biotechniques. 2002 Dec;33(6):1197-200. No abstract available.

PMID:
12503297
42.
43.

Hybrid papillomavirus L1 molecules assemble into virus-like particles that reconstitute conformational epitopes and induce neutralizing antibodies to distinct HPV types.

Christensen ND, Cladel NM, Reed CA, Budgeon LR, Embers ME, Skulsky DM, McClements WL, Ludmerer SW, Jansen KU.

Virology. 2001 Dec 20;291(2):324-34.

44.

Analysis of mechanisms underlying BRMS1 suppression of metastasis.

Samant RS, Seraj MJ, Saunders MM, Sakamaki TS, Shevde LA, Harms JF, Leonard TO, Goldberg SF, Budgeon L, Meehan WJ, Winter CR, Christensen ND, Verderame MF, Donahue HJ, Welch DR.

Clin Exp Metastasis. 2000;18(8):683-93.

PMID:
11827072
46.

In vivo anti-papillomavirus activity of nucleoside analogues including cidofovir on CRPV-induced rabbit papillomas.

Christensen ND, Pickel MD, Budgeon LR, Kreider JW.

Antiviral Res. 2000 Nov;48(2):131-42.

PMID:
11114415
47.

DNA vaccination prevents and/or delays carcinoma development of papillomavirus-induced skin papillomas on rabbits.

Han R, Cladel NM, Reed CA, Peng X, Budgeon LR, Pickel M, Christensen ND.

J Virol. 2000 Oct;74(20):9712-6.

48.

A broad-spectrum microbicide with virucidal activity against sexually transmitted viruses.

Howett MK, Neely EB, Christensen ND, Wigdahl B, Krebs FC, Malamud D, Patrick SD, Pickel MD, Welsh PA, Reed CA, Ward MG, Budgeon LR, Kreider JW.

Antimicrob Agents Chemother. 1999 Feb;43(2):314-21.

49.

Agarose-embedded tissue arrays for histologic and genetic analysis.

Tsao-Wu GS, Weber CH, Budgeon LR, Cheng KC.

Biotechniques. 1998 Oct;25(4):614-8.

PMID:
9793642
50.

Rabbit genital tissue is susceptible to infection by rabbit oral papillomavirus: an animal model for a genital tissue-targeting papillomavirus.

Harvey SB, Cladel NM, Budgeon LR, Welsh PA, Griffith JW, Lang CM, Christensen ND.

J Virol. 1998 Jun;72(6):5239-44.

Supplemental Content

Loading ...
Support Center